These results mirror those of other groups who have demonstrated that high-avidity serum anti-β2GPI antibodies are more closely associated with thrombosis than are low-avidity serum anti-β2GPI antibodies in patients with APS (35). This evidence concerns the gene APOH and Venous thrombosis.